FDA Warning Letter — Lusys Laboratories, Inc.

Case 625807 — FEI 3004473533

The FDA took a Warning Letter action against Lusys Laboratories, Inc. on Feb 18, 2022 (San Diego, CA). The action was issued by CDRH and concerns devices products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Lusys Laboratories, Inc.
Date
Feb 18, 2022
Fiscal Year
2022
Product Type
Devices
Center
CDRH
Location
San Diego, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.